Does Eliquis List Shortness of Breath as a Side Effect?
Yes, shortness of breath (dyspnea) is a reported side effect of Eliquis (apixaban), an anticoagulant used to prevent blood clots. Clinical trials and post-marketing data show it occurs in about 1-4% of patients, often linked to bleeding or hypersensitivity reactions rather than the drug directly.[1][2]
Why Might Eliquis Cause Shortness of Breath?
Eliquis thins the blood, raising bleeding risk in lungs (hemorrhage) or anemia from blood loss, both triggering breathlessness. Allergic reactions or interactions with other drugs (e.g., aspirin) can also contribute. It's not the most common side effect—major bleeding affects 2-3% yearly—but warrants monitoring.[1][3]
How Common Is It Compared to Other Anticoagulants?
| Drug | Shortness of Breath Rate | Major Bleeding Risk |
|------|---------------------------|---------------------|
| Eliquis (apixaban) | 1-4% | 2-3% per year [1] |
| Xarelto (rivaroxaban) | 2-5% | 3-4% per year [4] |
| Pradaxa (dabigatran) | 3-6% | 3-4% per year [4] |
| Warfarin | 4-7% | 3-5% per year [4] |
Eliquis has a lower overall bleeding risk than warfarin, but dyspnea rates are similar across NOACs.[3][4]
When Should You Worry About Shortness of Breath on Eliquis?
Seek immediate care if breathlessness comes with chest pain, coughing blood, dizziness, or swelling—signs of pulmonary embolism, lung bleed, or heart issues. Routine monitoring includes blood tests; report new symptoms to your doctor promptly.[1][2]
What Do Patients Report in Real-World Use?
User forums and FDA adverse event reports note dyspnea in 1,500+ Eliquis cases since 2012, often resolving after dose adjustment or switching meds. Some tie it to age (>65) or comorbidities like COPD.[5]
Can You Prevent or Manage It?
Dose reduction for kidney issues or elderly patients lowers risk. Avoid NSAIDs/alcohol; stay hydrated. If persistent, doctors may switch to another anticoagulant after weighing clot vs. bleed risks.[2][3]
Sources
[1]: Eliquis Prescribing Information (BMS/Pfizer)
[2]: FDA Eliquis Label
[3]: ARISTOTLE Trial (NEJM 2011)
[4]: Drugs.com Side Effect Comparisons
[5]: FDA FAERS Database